Want to see FOXO full AI Analyst Report?
FOXO Stock Chart & Stats
$0.01
-$0.02(-6.52%)
At close: 4:00 PM EST
$0.01
-$0.02(-6.52%)
Day’s Range― - ―
52-Week Range<$0.01 - $25.90
Previous CloseN/A
Volume722.65K
Average Volume (3M)10.82M
Market Cap
$306.27K
Enterprise Value$12.11M
Total Cash (Recent Filing)$65.90K
Total Debt (Recent Filing)$12.17M
Price to Earnings (P/E)―
Beta58.72
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,062,661,000
10 Day Avg. Volume5,970,242
30 Day Avg. Volume10,822,142
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)0.00162
P/FCF Ratio>-0.01
Enterprise Value/Market Cap39.54
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit1.29
Enterprise Value/Ebitda-1.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthFOXO's significant revenue growth indicates strong market demand and potential for scaling its innovative health solutions, enhancing long-term business prospects.
Strategic AcquisitionsStrategic acquisitions expand FOXO's service offerings and market reach, positioning the company for growth and improved competitive advantage in the healthcare sector.
Partnerships And CollaborationsPartnerships enhance FOXO's market position by leveraging external networks and expertise, facilitating access to new markets and diversified revenue streams.
Bears Say
High Debt LevelsHigh debt levels pose a risk to financial stability, potentially limiting FOXO's ability to invest in growth opportunities and manage economic downturns effectively.
Negative Cash FlowsPersistent negative cash flows challenge FOXO's ability to sustain operations without external financing, impacting long-term financial health and operational flexibility.
Going Concern UncertaintyGoing concern uncertainties reflect significant financial and operational challenges, raising doubts about FOXO's long-term viability and ability to meet future obligations.
FOXO Technologies News
FOXO FAQ
What was FOXO Technologies’s price range in the past 12 months?
FOXO Technologies lowest stock price was <$0.01 and its highest was $25.90 in the past 12 months.
What is FOXO Technologies’s market cap?
FOXO Technologies’s market cap is $306.27K.
When is FOXO Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were FOXO Technologies’s earnings last quarter?
Currently, no data Available
Is FOXO Technologies overvalued?
According to Wall Street analysts FOXO Technologies’s price is currently Overvalued.
Does FOXO Technologies pay dividends?
FOXO Technologies does not currently pay dividends.
What is FOXO Technologies’s EPS estimate?
FOXO Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FOXO Technologies have?
FOXO Technologies has 3,062,661,000 shares outstanding.
What happened to FOXO Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of FOXO Technologies?
Currently, no hedge funds are holding shares in FOXO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
FOXO Technologies
FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.
Technical Analysis
Healthcare Triangle
―
HeartBeam
―
EUDA Health Holdings
―
VSee Health
―
BullFrog AI Holdings, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---